Antiviral kombinationsbehandling er også blevet associeret med metaboliske abnormiteter som hypertriklycerid, hyperglykæmi, insulinresistens, hyperlaktatæmi (se afsnit 4. 4.)
Combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia (see section 4.4).